Inventor
STEINER SANDRA
CH16 patents
⚠️ This page may combine multiple inventors who share the name “STEINER SANDRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
10 patentsUS12209091B2Jan 28, 2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
HOFFMANN LA ROCHE7 citations85
US10730881B2Aug 4, 2020
Fused pyrimidine derivatives
HOFFMANN LA ROCHE2 citations73
US12344613B2Jul 1, 2025
EGFR inhibitor for the treatment of cancer
HOFFMANN LA ROCHE3 citations72
US11708354B2Jul 25, 2023
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
HOFFMANN LA ROCHE3 citations72
US11117890B2Sep 14, 2021
Substituted isoindole allosteric EGFR inhibitors
HOFFMANN LA ROCHE3 citations72
US10882848B2Jan 5, 2021
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
HOFFMANN LA ROCHE3 citations72
US12479849B2Nov 25, 2025
EGFR inhibitors for the treatment of cancer
HOFFMANN LA ROCHE0 citations60
US12421209B2Sep 23, 2025
Compounds
HOFFMANN LA ROCHE0 citations54
US11840528B2Dec 12, 2023
Isoxazolyl ether derivatives as GABAA α5 PAM
HOFFMANN LA ROCHE0 citations47
US10669276B2Jun 2, 2020
Fused pyrimidine derivatives
HOFFMANN LA ROCHE0 citations41
US HEALTH
3 patentsUS7642068B2Jan 5, 2010
Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor
US HEALTH24 citations87
US6815172B1Nov 9, 2004
Methods and compositions for opsonophagocytic assays
US HEALTH20 citations87
US7919104B2Apr 5, 2011
Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
US HEALTH4 citations58